Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

被引：21

作者：

Shao, Zhiying ^{[1
]}

Liu, Xin ^{[1
]}

Peng, Chanjuan ^{[1
]}

Wang, Liping ^{[1
]}

Xu, Dong ^{[1
]}

机构：

[1] Univ Chinese Acad Sci, Dept Intervent Ultrasound, Canc Hosp,Chinese Acad Sci, Zhejiang Canc Hosp,Inst Basic Med & Canc IBMC, 1 East Banshan Rd, Hangzhou 310022, Peoples R China

来源：

WORLD JOURNAL OF SURGICAL ONCOLOGY | 2021年 / 19卷 / 01期

关键词：

Hepatocellular carcinoma; Portal vein chemoembolization; Portal vein embolization; Transcatheter arterial chemoembolization; TRANSARTERIAL CHEMOEMBOLIZATION; VENOUS EMBOLIZATIONS; MAJOR HEPATECTOMY; TUMOR THROMBOSIS; LIVER; EFFICACY; DIAGNOSIS; CHEMOTHERAPY; SAFETY; TACE;

D O I：

10.1186/s12957-021-02401-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial chemoembolization. Main body Theoretically, portal vein embolization combined with transcatheter arterial chemoembolization may bring a breakthrough in the therapeutic effect of hepatocellular carcinoma. The feasibility, efficacy, long-term survival benefits, and side effects of the combined treatment have been explored in previous studies. Chemotherapeutic agents may also be added in the portal vein embolization procedure to further improve the treatment response. Conclusion In this study, we review the existing data and studies on the combined treatment in patients with hepatocellular carcinoma and provide an overall view of the strategy.

引用

页数：9

共 82 条

[1] Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma [J].

Aoki, T ;

Imamura, H ;

Hasegawa, K ;

Matsukura, A ;

Sano, K ;

Sugawara, Y ;

Kokudo, N ;

Makuuchi, M .

ARCHIVES OF SURGERY, 2004, 139 (07) :766-774

[2] Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma [J].

Azuma, Seishin ;

Asahina, Yasuhiro ;

Nishimura-Sakurai, Yuki ;

Kakinuma, Sei ;

Kaneko, Shun ;

Nagata, Hiroko ;

Goto, Fumio ;

Ootani, Satoshi ;

Kawai-Kitahata, Fukiko ;

Taniguchi, Miki ;

Murakawa, Miyako ;

Watanabe, Takako ;

Tasaka-Fujita, Megumi ;

Itsui, Yasuhiro ;

Nakagawa, Mina ;

Watanabe, Mamoru .

HEPATOLOGY RESEARCH, 2016, 46 (04) :312-319

[3]

Bai-Ren, 2011, MED INNOV CHINA, V08, P17

[4]

[中华人民共和国卫生和计划生育委员会医政医管局 Bureau of Medical Administration Nation], 2017, [中华消化外科杂志, Chinese Journal of Digestive Surgery], V16, P635

[5]

Chen H., 1995, MED J COMMUN, V9, P9

[6] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection [J].

Chen, Xiaohong ;

Zhang, Boheng ;

Yin, Xin ;

Ren, Zhenggang ;

Qiu, Shuangjian ;

Zhou, Jian .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) :773-781

[7] The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis [J].

Cheng, Zhoujing ;

He, Lin ;

Guo, Yingjie ;

Song, Yuhua ;

Song, Shasha ;

Zhang, Lijiu .

WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)

[8]

Choi Jeong-Heon, 2015, Korean J Hepatobiliary Pancreat Surg, V19, P59, DOI 10.14701/kjhbps.2015.19.2.59

[9] Percutaneous Transsplenic Access to the Portal Vein for Management of Vascular Complication in Patients with Chronic Liver Disease [J].

Chu, Hee Ho ;

Kim, Hyo-Cheol ;

Jae, Hwan Jun ;

Yi, Nam-Joon ;

Lee, Kwang-Woong ;

Suh, Kyung-Suk ;

Chung, Jin Wook ;

Park, Jae Hyung .

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 35 (06) :1388-1395

[10]

[代柏树 Dai Baishu], 2019, [中国普通外科杂志, Chinese Journal of General Surgery], V28, P188

← 1 2 3 4 5 6 7 8 9 →